Dermatology — a weekly podcast briefing of the most significant peer-reviewed dermatology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc. India edition.
Editor's Pick: 52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study (Journal of the American Academy of Dermatology, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Dermatology. This week we're covering 10 notable papers spanning cutaneous oncology and immunotherapy, long-term management of inflammatory skin disease, and the harder edges of blistering, metabolic and genetic skin condition…
This week's papers:
1. Relatlimab plus nivolumab versus nivolumab for advanced melanoma: 5-year survival and biomarker analyses of the phase 3 RELATIVITY-047 trial. — Nature Medicine 2026
2. Intralesional cemiplimab for patients with early-stage cutaneous squamous cell carcinoma: Results from a dose-escalation study with expansion cohorts. — Journal of the American Academy of Dermatology 2026
3. Targeted and Immune-Based Therapies in Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis. — JAMA Dermatology 2026
4. A randomised double-blind placebo-controlled trial of topical menthol for pain relief during photodynamic therapy. — Clinical and Experimental Dermatology 2026
5. 52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study. — Journal of the American Academy of Dermatology 2026
6. Phenome-wide Longitudinal Association Study of Hospital-recorded Comorbidity in Psoriasis. — British Journal of Dermatology 2026
7. Vitamin D status and systemic inflammatory burden as a predictor of biologic treatment response in psoriasis -A pilot study in Northern Ireland. — Clinical and Experimental Dermatology 2026
8. Site-Specific Treatment and Remission Patterns in Multisite Mucous Membrane Pemphigoid. — JAMA Dermatology 2026
9. Estrogen Use and Porphyria Cutanea Tarda. — JAMA Dermatology 2026
10. Understanding the Experiences and Needs of Parents With Children With Epidermolysis Bullosa. A Qualitative Study to Inform the Development of a Self-help Toolk… — British Journal of Dermatology 2026
Listen at https://audioscholar.cc/episode/k7q4tr8fad
24 Oct 2026
This Week in Dermatology — Oct 23, 2026
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Dermatology. This week we're covering 10 notable papers spanning a major push in hidraden…
This week's papers:
1. Joint American Academy of Dermatology-Hidradenitis Suppurativa Foundation guidelines of care for the management of hidradenitis suppurativa. — Journal of the American Academy of Dermatology 2026
2. HiSQOL-mini: Development and Validation of a Shortened Version of the Hidradenitis Suppurativa Quality of Life (HiSQOL) Instrument. — British Journal of Dermatology 2026
3. Optimizing surgery in hidradenitis suppurativa. — Journal of the European Academy of Dermatology and Venereology 2026
4. Hidradenitis suppurativa skin microbiome: In-depth analysis and modulation by systemic therapies. — Journal of the European Academy of Dermatology and Venereology 2026
5. Efficacy and safety of litifilimab in cutaneous lupus erythematosus: 24-week results of the randomized phase 2 study, AMETHYST. — Journal of the American Academy of Dermatology 2026
6. Efficacy and safety of QY201, an oral dual Janus kinase 1/tyrosine kinase 2 inhibitor, in adults with moderate-to-severe atopic dermatitis: a multicenter, rand… — Journal of the American Academy of Dermatology 2026
7. Psoriasis: Which therapy for which patient, updated, part I. Focus on Psoriasis Comorbidities and Preferred Systemic Agents. — Journal of the American Academy of Dermatology 2026
8. Psoriasis: Which therapy for which patient, updated, part II. Focus on special populations and chronic infections. — Journal of the American Academy of Dermatology 2026
9. Evaluating the Performance of Melanoma Risk Prediction Models. — JAMA Dermatology 2026
10. Extramammary Paget's Disease With Bilateral Sentinel Lymph Node Biopsy: a Multicenter Study of Lymphatic Patterns and Outcomes. — Clinical and Experimental Dermatology 2026
Listen at https://audioscholar.cc/episode/n9uy8g4nbs
17 Oct 2026
This Week in Dermatology — Oct 16, 2026
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Dermatology. This week we're covering 10 notable papers spanning cancer risk in chronic i…
This week's papers:
1. Cancer Risk in Patients With Overall and Site-Specific Lichen Planus. — JAMA Dermatology 2026
2. Female genital lichen sclerosus. — Journal of the European Academy of Dermatology and Venereology 2026
3. Experience-based recommendations for the diagnosis and management of early-stage nail unit melanoma. — Journal of the European Academy of Dermatology and Venereology 2026
4. Real-time assessment of mitotic rate in malignant melanoma by ex vivo confocal microscopy. — Clinical and Experimental Dermatology 2026
5. Upadacitinib Combined with NB-UVB for Non-Segmental Vitiligo: A Single-Center Prospective Study. — Clinical and Experimental Dermatology 2026
6. Vitiligo Biomarker CXCL10 Correlates With Clinical Response to Ruxolitinib Cream in the Phase 2 Randomized TRuE-V Mechanism-of-Action Study. — Journal of Investigative Dermatology 2026
7. UVA1 Phototherapy in a national reference center:A 10-year systematical analysis. — Dermatology 2026
8. LABD97 IgG ELISA increases sensitivity of ELISA serologic testing for the diagnosis of bullous pemphigoid. — Journal of the American Academy of Dermatology 2026
9. Device-Free Auricular Acupressure for Rosacea: A Randomized Clinical Trial. — JAMA Dermatology 2026
10. Optimizing therapy in hidradenitis suppurativa: Combination, sequencing and treat-to-target. — Journal of the European Academy of Dermatology and Venereology 2026
Listen at https://audioscholar.cc/episode/44qect7b45
Contact AudioScholar Dermatology Weekly (India)
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of AudioScholar Dermatology Weekly (India)?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
